Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 15 2021 - 7:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2021
Commission File Number: 001-34541
GLOBAL CORD BLOOD CORPORATION
(Translation of registrants name into English)
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
This report and the exhibit to this report are hereby incorporated by reference into the registration statements on Form F-3 (No. 333-183143 and No. 333-233880) of the Company.
On March 15, 2021, the Company issued a press release announcing the formation of a special committee of its Board of Directors in response to its receipt of a proposal letter on March 2, 2021. A copy of the press release is attached hereto as Exhibit 99.1.
Exhibits
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release dated March 15, 2021
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GLOBAL CORD BLOOD CORPORATION
|
|
|
|
By:
|
/s/ Albert Chen
|
|
Name:
|
Albert Chen
|
|
Title:
|
Chief Financial Officer
|
|
|
Dated: March 15, 2021
|
|
3
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Sep 2023 to Sep 2024